follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      TCON stock
      Biotechnology

      TCON Stock Jumps 15% After Collaborative Agreement for Envafolimab

      Dec 20 Ankit Singhania
      The current week has seen a few important deals in the pharmaceutical world, and another one was announced this morning by TRACON Pharmaceuticals Inc (NASDAQ:TCON). Following the news, TCON stock soared over 18%. Big News ... [Read]
      RAD stock
      Retail

      RAD Stock Soars 45% After Reporting Q3 Profit, Beats Estimate

      Dec 19 Ankit Singhania
      RAD stock is witnessing its biggest one day gain in the past 30 years after Rite Aid Corporation (NYSE:RAD) swung to a third-quarter profit. The frenetic pace of seasonal earnings announcements may have ended, but ... [Read]
      BevCanna
      Cannabis

      Could BevCanna Enterprises Inc. (CSE:BEV) (OTC:BVNNF) (FRA:7BC) Be The Monster Energy of Cannabis?

      Dec 18 Ankit Singhania
      As the broader cannabis sector is trading near the oversold zone, now it’s the right time to consider the right company with strong potential. Based on the technical and fundamental analysis, we think BevCanna (CSE:BEV) ... [Read]
      MIRM stock
      Biotechnology

      MIRM Stock Hits New High: Jumps 210% on Maralixibat Optimism

      Dec 18 Ankit Singhania
      Meetings with the United States Food and Drug Administration are always key events for any pharmaceutical company, and it is especially so when it comes to a pre-New Drug Application (NDA). On Monday this week, ... [Read]
      PEIX stock
      Oil & Gas

      PEIX Stock Soars 20% on Successful Negotiation with Lenders

      Dec 17 Ankit Singhania
      PEIX stock is one of the biggest gainers in Tuesday’s trading session after Pacific Ethanol Inc (NASDAQ:PEIX) negotiated terms with lenders for the extension of its debt. Immediate Relief In a development that must have ... [Read]
      ONVO stock
      Medical

      ONVO Stock Soars on Merger with Tarveda Therapeutics

      Dec 16 Ankit Singhania
      Merger announcements often result in stock price movements, and that is what happened with ONVO stock this morning. This morning, Organovo Holdings Inc (NASDAQ:ONVO) announced it has entered into an agreement for one of its ... [Read]
      Active Mover List
      Market Movers

      Meta Growth (TSXV:META) (OTCMKTS:NACNF) Is All Set To Make Solid Movement In Coming Sessions

      Dec 13 Ankit Singhania
      Meta Growth has been a rising star this week in the Cannabis Markets. The stock is up 41% since December 4th and is currently sitting at $0.24 and hit a high of $0.255 on Friday ... [Read]
      GLUU stock
      Communications

      GLUU Stock Tumbles 50% from Highs: Will It Recover in 2020?

      Dec 13 Ankit Singhania
      Back in April this year, mobile and tablet games developer Glu Mobile Inc. (NASDAQ:GLUU) had hit as much as $11.75 a share; however, since then, GLUU stock has nosedived due to a drop in sales. ... [Read]
      AMRX stock
      Drug Manufacturers

      AMRX Stock Soars as FDA Approves EluRyng: Next Steps

      Dec 12 Ankit Singhania
      When it comes to significant movements in the stock price of a pharmaceutical company, then there are very few triggers that are better than that of positive development with regards to a product in the ... [Read]
      GME stock
      Retail

      GME Stock Drops 20% After GameStop Slashes Full-Year Guidance

      Dec 11 Ankit Singhania
      GME stock plunged 20% on Wednesday after GameStop Corp. (NYSE:GME) announced uninspiring Q3 2019 earnings results. The company slashed its full-year profit guidance as it continues to grapple with delays in the purchase of consoles ... [Read]

      Posts pagination

      « 1 … 9 10 11 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE TRACON Pharmaceuticals Email Alerts
      Get FREE TRACON Pharmaceuticals Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x